We are pleased to announce that Sickle Cell in Focus (SCiF) will take place in 2021 for the 14th annual conference on September 30 & October 1, 2021. The SCiF conference will once again be co-hosted by the National Heart, Lung, and Blood Institute and the University of West Indies (Jamaica). Due to current travel restrictions, this year’s conference will be held virtual via Zoom.
SCiF is a two-day, intensive, educational update on sickle cell disease. We aim to provide consultants, trainees, doctors, healthcare professionals, and academics interested in hemoglobin disorders with an opportunity for a comprehensive and global exploration of the current medical trends and research results in sickle cell disease. SCiF 2021 will highlight emerging clinical and management issues relating to sickle cell disease, emerging therapies and how we can use them in combination for effective treatment, and in light of the recent pandemic, we will also have a session on the impact of COVID-19 on patients with sickle cell disease. Each day will convene with a panel discussion; the first on FDA approved drugs and the second on the issue of gene therapy vs bone marrow transplant.
If you would like to receive a recording of the event, please email firstname.lastname@example.org.
In support of improving patient care, this activity has been planned and implemented by CME outfitters, LLC and The National Heart Lung and Blood Institute. CME Outfitters, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME Outfitters, LLC, designates this Live activity for a maximum of 11.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: This activity is designated for 11.75 ANCC contact hours.